These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 14780333)
1. An adverse effect of BAL in a case of subacute arsenical polyneuritis, with observations on porphyrin metabolism. SANDS JH; BERRIS B; SCHERER LR N Engl J Med; 1950 Oct; 243(15):558-61. PubMed ID: 14780333 [No Abstract] [Full Text] [Related]
2. Use of BAL in the treatment of arsenical neuropathy. MALHOTRA SL Ind Med Gaz; 1951 Aug; 86(8):340-3. PubMed ID: 14888288 [No Abstract] [Full Text] [Related]
5. The fate of arsenical vesicants in the skin and the effect of BAL (British anti-lewisite). Graham AF; Levvy GA; Chance AC Biochem J; 1947; 41(3):352-7. PubMed ID: 16748172 [No Abstract] [Full Text] [Related]
6. Clinical uses of 2,3-dimercaptopropanol (BAL); the effect of BAL on the excretion of arsenic in arsenical intoxication. LUETSCHER JA; EAGLE H; LONG-COPE WT J Clin Invest; 1946 Jul; 25(4):534-40. PubMed ID: 21001627 [No Abstract] [Full Text] [Related]
7. [BAL in the treatment of intoxication by arsenical and gold preparations]. BERMUDEZ ABREU VP Rev Kuba Med Trop Parasitol; 1950; 6(3-4):59-65. PubMed ID: 15441436 [No Abstract] [Full Text] [Related]
8. Suppression of treponemicidal action of arsenic with 2,3-dimercaptopropanol (BAL) report of clinical observations in five cases. De OREO GA Arch Derm Syphilol; 1947 Nov; 56(5):695-8. PubMed ID: 20272216 [No Abstract] [Full Text] [Related]
9. Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of arsenical dermatitis with preparations of BAL. LONGCOPE WT; LUETSCHER JA J Clin Invest; 1946 Jul; 25(4):528-33. PubMed ID: 21001626 [No Abstract] [Full Text] [Related]
10. [Two cases of severe arsenical erythroderma, successfully treated with the new BAL compound]. NOGUER-MORE Actas Dermosifiliogr; 1948 Jan; 39(4):498-507. PubMed ID: 18865721 [No Abstract] [Full Text] [Related]
11. British anti-lewisite; a report on its use and therapeutic value in arsenical intoxications, from the BAL Conference, Medical Research Council. PETERS RA; BENNET J Br Med J; 1947 Oct; 2(4526):520. PubMed ID: 20267003 [No Abstract] [Full Text] [Related]
12. Tryparsamide optic neuritis treated by 2,3 dimercaptopropanol (BAL). FRIEDENBERG S J Am Med Assoc; 1947 Dec; 135(16):1072. PubMed ID: 18897608 [No Abstract] [Full Text] [Related]
14. Arsenical encephalopathy treated with B. A. L. KONAR NR; DASS AK Calcutta Med J; 1950 Jun; 47(6):188-90. PubMed ID: 14772650 [No Abstract] [Full Text] [Related]
15. A case of industrial arsenical cancer occurring for the first time in Hungary and a comprehensive analysis of it. FRANK G Acta Derm Venereol; 1950; 30(2):163-72. PubMed ID: 15410558 [No Abstract] [Full Text] [Related]
16. An explosive reaction following the simultaneous administration of sodium arsenite and dithioglycerol (BAL) in vivo. KOPPANYI T; SPERLING F Anat Rec; 1946 Dec; 96(4):501. PubMed ID: 20341381 [No Abstract] [Full Text] [Related]
17. [Certain comments on arsenical polyneuritis]. BARRAQUER-FERRE L; CASTANER-VENDRELL E; RUIZ-LARA R Prensa Med Argent; 1952 Sep; 39(38):2230-7. PubMed ID: 12993709 [No Abstract] [Full Text] [Related]
18. [Anatomoclinical observation of a pellagroid syndrome with porphyrinuria associated with polyneuritis and hepatic cirrhosis]. PALIARD F; PLAUCHU M; BERTOYE A; EXBRAYAT C Lyon Med; 1950 Oct; 183(44):273-81. PubMed ID: 14785309 [No Abstract] [Full Text] [Related]
19. [Arsenical erythroma extinguished by B.A.L. and sodium thiosulfate]. SMITH H Union Med Can; 1949 Dec; 78(12):1437. PubMed ID: 15394898 [No Abstract] [Full Text] [Related]
20. [Poisoning with arsenical gases and heavy metals and the possibility of their treatment]. POPOVIC V Vojnosanit Pregl; 1951; 8(1-2):35-8. PubMed ID: 14836470 [No Abstract] [Full Text] [Related] [Next] [New Search]